tiprankstipranks
Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ:TARS
US Market
Want to see TARS full AI Analyst Report?

Tarsus Pharmaceuticals (TARS) Blogger Opinions & Sentiment

282 Followers

Blogger Sentiment

Bullish: 80.00%
Sector Average
Bullish
TARS Blogger sentiment is based on 5 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
60% SeekingAlpha
20% GuruFocus
20% Investing
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Is Tarsus Pharmaceuticals (TARS) Positioned for Growth After Q2 Earnings Beat with Revenue of $173.9 Million? GF Score: 46/100
GuruFocus
Tarsus: Not Cheap, But Xdemvy Makes The Valuation Work
SeekingAlpha
Tarsus Pharmaceuticals: Q4 Results Highlight Xdemvy Blockbuster Potential
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of TARS?
Seeking Alpha’s Joshua Fineman has a Bearish Sentiment.
    What do Motley Fool contributors think of TARS?
    Currently there's no blogger sentiment for TARS.
    What Is TARS’s Blogger Sentiment?
    TARS’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for TARS?
      The most recent blogger prediction for TARS was made by GuruFocus News, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          CADLCandel Therapeutics
          MLTXMoonLake Immunotherapeutics
          SMMTSummit Therapeutics
          TGTXTG Therapeutics
          PGENPrecigen